148 related articles for article (PubMed ID: 21289023)
21. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
[TBL] [Abstract][Full Text] [Related]
22. Central retinal vein occlusion in a patient after being commenced on sildenafil citrate for pulmonary arterial hypertension.
Pinto LM; Morekar S; Mahashur AA
Indian J Chest Dis Allied Sci; 2009; 51(4):249-51. PubMed ID: 20073379
[TBL] [Abstract][Full Text] [Related]
23. ERG evaluation of daily, high-dose sildenafil usage.
Zoumalan CI; Zamanian RT; Doyle RL; Marmor MF
Doc Ophthalmol; 2009 Jun; 118(3):225-31. PubMed ID: 18818963
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic approaches to pulmonary hypertension in hemoglobinopathies: Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy.
Derchi G; Forni GL
Ann N Y Acad Sci; 2005; 1054():471-5. PubMed ID: 16339700
[TBL] [Abstract][Full Text] [Related]
25. Sildenafil and mild pulmonary arterial hypertension: unjustified risks, with no tangible benefit.
Prescrire Int; 2010 Oct; 19(109):206. PubMed ID: 21180373
[No Abstract] [Full Text] [Related]
26. Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.
Abman SH; Kinsella JP; Rosenzweig EB; Krishnan U; Kulik T; Mullen M; Wessel DL; Steinhorn R; Adatia I; Hanna B; Feinstein J; Fineman J; Raj U; Humpl T;
Am J Respir Crit Care Med; 2013 Mar; 187(6):572-5. PubMed ID: 23220921
[TBL] [Abstract][Full Text] [Related]
27. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
[No Abstract] [Full Text] [Related]
28. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.
Sebkhi A; Strange JW; Phillips SC; Wharton J; Wilkins MR
Circulation; 2003 Jul; 107(25):3230-5. PubMed ID: 12796132
[TBL] [Abstract][Full Text] [Related]
29. Intracerebral hemorrhage associated with sildenafil use: a case report.
Alpsan MH; Bebek N; Ciftci FD; Coban O; Bahar S; Tuncay R
J Neurol; 2008 Jun; 255(6):932-3. PubMed ID: 18465112
[No Abstract] [Full Text] [Related]
30. Long-term treatment with high-dose of sildenafil in a thalassemic patient with pulmonary hypertension.
Correale M; De Rosa F; Ieva R; Di Biase M; Brunetti ND
Monaldi Arch Chest Dis; 2012 Jun; 78(2):105-6. PubMed ID: 23167153
[TBL] [Abstract][Full Text] [Related]
31. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
32. Vertebral artery dissection associated with sildenafil abuse.
Dersch R; Anastasopoulos C; Hader C; Stich O
J Clin Neurosci; 2013 May; 20(5):742. PubMed ID: 23454143
[TBL] [Abstract][Full Text] [Related]
33. 69-year-old woman with ascites, hypoxia, and weight loss.
Prasad M; Wilson ME; McGoon MD
Mayo Clin Proc; 2013 Dec; 88(12):1475-9. PubMed ID: 24290122
[No Abstract] [Full Text] [Related]
34. Dramatic decrease in the pulmonary artery systolic pressure and disappearance of the interatrial shunt with sildenafil treatment in a patient with primary pulmonary hypertension with atrial septal aneurysm and a severe right to left shunt through the patent foramen ovale.
Karakaya O; Ozdemir N; Kaymaz C; Barutcu I
Int J Cardiol; 2006 Jun; 110(1):97-9. PubMed ID: 16507322
[TBL] [Abstract][Full Text] [Related]
35. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease.
Mourani PM; Sontag MK; Ivy DD; Abman SH
J Pediatr; 2009 Mar; 154(3):379-84, 384.e1-2. PubMed ID: 18950791
[TBL] [Abstract][Full Text] [Related]
36. Sildenafil: emerging cardiovascular indications.
Raja SG; Nayak SH
Ann Thorac Surg; 2004 Oct; 78(4):1496-506. PubMed ID: 15464535
[TBL] [Abstract][Full Text] [Related]
37. Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension.
Goland S; Tsai F; Habib M; Janmohamed M; Goodwin TM; Elkayam U
Cardiology; 2010; 115(3):205-8. PubMed ID: 20173324
[TBL] [Abstract][Full Text] [Related]
38. Viagra and health: beyond ED.
Harv Mens Health Watch; 2007 Aug; 12(1):1-4. PubMed ID: 18018319
[No Abstract] [Full Text] [Related]
39. Clinical response to sildenafil in pulmonary hypertension associated with Gaucher disease.
Fernandes CJ; Jardim C; Carvalho LA; Farias AQ; Filho MT; Souza R
J Inherit Metab Dis; 2005; 28(4):603-5. PubMed ID: 15902565
[TBL] [Abstract][Full Text] [Related]
40. Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study.
Frantz RP; Durst L; Burger CD; Oudiz RJ; Bourge RC; Franco V; Waxman AB; McDevitt S; Walker S
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):550-7. PubMed ID: 24742768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
